New Research Poster Presentation 6.28
Metadoxine: A Novel Pro-Cognitive Drug Modulating the Gamma-Aminobutyric Acid Ergic System for Treatment of Cognitive Disorders

Saturday, October 31, 2015 10:00 AM
Johanna Schumann, PhD, Alcobra Pharma, Tel Aviv, Israel
Jonathan Rubin, MD, MBA, Alcobra Pharma, Philadelphia, PA
Yaron Daniely, MBA, PhD, Alcobra Pharma, Tel Aviv, Israel
Lee Crossman, BS, Covance Laboratories Limited, Harrogate, United Kingdom
Anne Marie Hernier, BS, Porsolt Laboratory, Le Genest-Saint-Isle, France
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.